Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial
Yong Zhang(Sun Yat-sen University), Ming Shi(Southwest Jiaotong University), Zhouyi Wang(Central South University), Shenghua Zong(Kingmed Diagnostics), Hao Chen(Icahn School of Medicine at Mount Sinai), Xue Du(Xuzhou Medical College), Guiyun Cui(Xuzhou Medical College), Guoyan Qi(Hebei Medical University), Jiang Cao(Xuzhou Medical College), Junnian Zheng(Xuzhou Medical College), Shenyang Zhang(Xuzhou Medical College), Zhouao Zhang(Xuzhou Medical College), Gang Wang(Jiangsu University), Wei Zhang(Fudan University), Xiaoyu Huang(Xuzhou Medical College), Tiancheng Luo(Sun Yat-sen University), Huizhong Li(Jiangsu University), Dan Liu(Xuzhou Medical College), Shengli Li(Xuzhou Medical College), Mingjin Yang(Xuzhou Medical College), Tianyu Ma(Xuzhou Medical College), Xinyan Guo(Xuzhou Medical College)
Cited by 12
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189
Structural diversity of the gnih/gnih receptor system in teleost: Its involvement in early development and the negative control of LH release
|Peptides|2010|147
The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects
|Frontiers in Immunology|2024|136